0
Upcoming Allied Market Research
2023
Biotechnology Services Market

Biotechnology Services Market

Size, Share, Competitive Landscape and Trend Analysis Report by Service Type (Public Engagement Activities, Health Education and Research, Food Biotechnology Services, Donor Recruitment, Tissue Collection, Cell Processing and Isolation, Research and Development), by Industry (Clinical Research Organizations(CROs), Contract Manufacturers Organizations (CMOs), Contract Research and Manufacturing Services (CRAMS)) and by Application (Pharmaceutical, Biotechnological, Academic, Clinical Trial, Healthcare Sectors): Global Opportunity Analysis and Industry Forecast, 2023-2032

Report Code: A12476
Pages: NA
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

Biotechnology Services Market Overview 2030:

Biotechnology is an interdisciplinary, innovative field that utilizes living organisms, biological systems, or derivatives to modify or develop processes and outcomes for producing healthcare-related products and therapeutics. It has profound impact on different sectors such as medicine & pharmaceuticals, genomics, and production of food & chemicals. It has comprehensive and significant use in solving critical challenges related to health & well-being, food & energy supply, and environmental protection.

The biotechnology services market consists of the sales of biotechnology services and related goods by entities (organizations, sole traders, and partnerships) that engage in conducting research and experimental development in biotechnology. Only goods and services traded between entities or sold to end consumers are included.

COVID-19 Impact Analysis

  • COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
  • Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the biotechnology services market.
  • COVID-19 has impacted the demand and supply chain of biotechnological services. Lockdown in most of the countries has impacted the production of raw materials. COVID-19 testing kits in later stage of the disease created demand in market. Vaccines and home testing kits have witnessed a surge in the market.
  • Repurposing use of biotechnological products such as Tocilizumab, a monoclonal antibody in COVID-19 management has created high demand for such biotechnologically developed drugs, which has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs.
  • Biotechnology services market is expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19.

Top Impacting Factors

  • Increase in the pervasiveness of conditions like hepatitis B, diabetes, and cancer is driving the research in biotechnology. Biotechnology uses research tools from biology and chemistry to study the genetic material of bacteria and viruses to check the disease-producing agent. Oncology research is most prominent among biopharma companies. Stem cell treatment using a monoclonal antibody for therapy and genome sequencing are progressing in medical applications.
  • According to data-driven investor, all sectors of biotech companies together spend 20% of their budget on R&D. Therefore, the increase in the pervasiveness of diseases and huge expenses on R&D are predicted to contribute to the growth of the biotechnology services market.
  • Risk related to genetic data is anticipated to limit the growth of the biotechnology services market. The biotechnological approach of transferring specially created genes for modification in characteristics to create genetically modified organisms (GMOs) has always been considered a threat to human and environmental health. According to the report of the World Conservation Union, numerous environmental risks are likely to occur by the use of GMOs, which include interbreeding, antibiotic resistance, impact on the ecosystem, creation of new or worse viruses, competition with natural species, unpredictable &unintended effects, and ethical concerns.
  •  The National Bioengineered Food Disclosure Standard has been implemented in the U.S. from January 2020, making it mandatory to label all foods containing genetically engineered items to be labeled as "bioengineered.” Thus, the risk associated with genetically modified items has negatively impacted the growth of the biotechnology services market.

Market Trends

The outsourcing of clinical trials, drug discovery, and contract manufacturing has recently emerged as a trend in several developed economies. As a result of this, the bio-services market has grown robustly in developing countries such as China, Thailand, Malaysia, and India, as these countries are investing in the R&D projects for the development of innovative bio-services. The Bio-services have potential opportunities in emerging economies owing to the regulatory support by governments, easy raw material availability, and cheap labor. The global bio-service industry is likely to surge due to its low operating costs.

The market growth is further expected to be propelled by the rise in awareness among consumers with regard to bio-services and government initiatives in emerging economies.

In May 2018, Illumina, a U.S.-based biotechnology company serving in research, clinical, and applied markets, acquired Edico Genome for an undisclosed amount. The acquisition is expected to reduce sequencing data acquisition. Edico Genome's Bio-IT platform DRAGEN uses field-programmable gate array (FPGA) technology with software algorithms and helps in reducing data footprint and time for results. The DRAGEN platform complements Illumina's sequencing portfolio and helps the customer in reducing investment in IT infrastructure and improve overall efficiency. Edico Genome is an American company dealing in the field of genomics.

Key Benefits of Report

  • This report presents the detailed analytical depiction of the biotechnology services market along with current trends, opportunities, and future estimates for the investment in market.
  • The report presents information related to the key drivers, restraints, and new technological development in the market.
  • The current market is analyzed to emphasize the biotechnology services market.
  • Porter’s five forces analysis illustrate the potency of buyers and suppliers in market.
  • The report provides detailed analysis of the biotechnology services market based on market competition and how it is anticipated to take shape in upcoming years.

Questions Answered in the Biotechnology Services Market Report

  • What consists of biotechnology services market?
  • What are current trends that will influence the market in upcoming years?
  • What are the driving factors, restraints, and opportunities of the market?
  • Which are the leading players in the biotechnology services market?
  • What future projections will help in taking strategic steps in the future?
  • Which are the major end user sectors in biotechnology services market?
  • What is the major regional market in biotechnology services market?
  • What are the key benefits of this biotechnology services market report?

Biotechnology Services Market Report Highlights

Aspects Details
By Service Type
  • Public Engagement Activities
  • Health Education and Research
  • Food Biotechnology Services
  • Donor Recruitment
  • Tissue Collection
  • Cell Processing and Isolation
  • Research and Development
By Industry
  • Clinical Research Organizations(CROs)
  • Contract Manufacturers Organizations (CMOs)
  • Contract Research and Manufacturing Services (CRAMS)
By Application
  • Pharmaceutical
  • Biotechnological
  • Academic
  • Clinical Trial
  • Healthcare Sectors
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Sanofi S.A., BioAlps, Novartis AG, Sartorius, Aldevron LLC, Fisher BioService Corp, F. Hoffmann-La Roche Ltd., Novo Nordisk, Precision for Medicine, Pfizer Ltd
 

Loading Table Of Content...


 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Purchase Options

Call or Email Us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Biotechnology Services Market

Start reading.
This Report and over 71,233+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

Related Reports
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of the scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time for readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of the scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save the time of readers